Fairmount Funds Management’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $74.7M | Hold |
|
|||||
|
2025
Q2 | $48.4M | Buy |
|
|||||
|
2025
Q1 | $46.4M | Hold |
|
|||||
|
2024
Q4 | $66.1M | Hold |
|
|||||
|
2024
Q3 | $78.4M | Buy |
|
|||||
|
2024
Q2 | $24M | Hold |
|
|||||
|
2024
Q1 | $32.3M | Buy |
|
|||||
|
2023
Q4 | $29.8M | Hold |
|
|||||
|
2023
Q3 | $21M | Hold |
|
|||||
|
2023
Q2 | $32.6M | Hold |
|
|||||
|
2023
Q1 | $34.8M | Hold |
|
|||||
|
2022
Q4 | $40M | Hold |
|
|||||
|
2022
Q3 | $28.1M | Buy |
|
|||||
|
2022
Q2 | $10.9M | Hold |
|
|||||
|
2022
Q1 | $17.5M | Hold |
|
|||||
|
2021
Q4 | $18.7M | Hold |
|
|||||
|
2021
Q3 | $15.5M | Buy |
|
|||||
|
2021
Q2 | $642K | Hold |
|
|||||
|
2021
Q1 | $581K | Hold |
|
|||||
|
2020
Q4 | $554K | Buy |
|